Delving into the Latest Updates on Wuxi Zhikang Hongren New Drug Development Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Other Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Small molecule drug	1

Primary objective: To evaluate the safety and tolerability of single ascending dose and multiple ascending dose oral administration of SC1011 tablets in healthy adults. Secondary objective: To evaluate the effect of food intake on the pharmacokinetics of single oral administration of SC1011 tablets in healthy adults.

Start Date27 May 2021

Sponsor / Collaborator

Wuxi Zhikang Hongren New Drug Development Co., Ltd.

100 Clinical Results associated with Wuxi Zhikang Hongren New Drug Development Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Wuxi Zhikang Hongren New Drug Development Co., Ltd.

Login to view more data

100 Deals associated with Wuxi Zhikang Hongren New Drug Development Co., Ltd.

Login to view more data

100 Translational Medicine associated with Wuxi Zhikang Hongren New Drug Development Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data